Reproxalap Improves Signs and Symptoms of Allergic Conjunctivitis in an Allergen Chamber: A Real-World Model of Allergen Exposure
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reproxalap Improves Signs and Symptoms of Allergic Conjunctivitis in an Allergen Chamber: A Real-World Model of Allergen Exposure
Authors
Keywords
-
Journal
Clinical Ophthalmology
Volume Volume 16, Issue -, Pages 15-23
Publisher
Informa UK Limited
Online
2022-01-03
DOI
10.2147/opth.s345324
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Randomized Double-Masked Phase 2a Trial to Evaluate Activity and Safety of Topical Ocular Reproxalap, a Novel RASP Inhibitor, in Dry Eye Disease
- (2021) David Clark et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Clinically Relevant Activity of the Novel RASP Inhibitor Reproxalap in Allergic Conjunctivitis: The Phase 3 ALLEVIATE Trial
- (2021) David Clark et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Early Onset and Broad Activity of Reproxalap in a Randomized, Double-Masked, Vehicle-Controlled Phase 2b Trial in Dry Eye Disease
- (2021) David Clark et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Randomized Phase 2 Trial of Reproxalap, a Novel Reactive Aldehyde Species Inhibitor, in Patients with Noninfectious Anterior Uveitis: Model for Corticosteroid Replacement
- (2020) Kenneth J. Mandell et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Allergic Conjunctivitis: A National Cross-Sectional Study of Clinical Characteristics and Quality of Life
- (2018) Jorge Palmares et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- Effect of olopatadine-mometasone combination nasal spray on seasonal allergic rhinitis symptoms in an environmental exposure chamber study
- (2018) Piyush Patel et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Ocular itch associated with allergic conjunctivitis: latest evidence and clinical management
- (2016) Stacey Ackerman et al. Therapeutic Advances in Chronic Disease
- Allergic conjunctivitis: a cross-sectional study
- (2015) A. Leonardi et al. CLINICAL AND EXPERIMENTAL ALLERGY
- A Phase 2 Exploratory Study of a Novel Interleukin-1 Receptor Inhibitor (EBI-005) in the Treatment of Moderate-to-Severe Allergic Conjunctivitis
- (2015) Michael H. Goldstein et al. Eye & Contact Lens-Science and Clinical Practice
- A proof-of-concept study of the effect of a novel H3-receptor antagonist in allergen-induced nasal congestion
- (2013) William T. Barchuk et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Allergic conjunctivitis and dry eye syndrome
- (2012) Milton M. Hom et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Cell signalling by reactive lipid species: new concepts and molecular mechanisms
- (2012) Ashlee Higdon et al. BIOCHEMICAL JOURNAL
- Oxidative stress activates NLRP3 inflammasomes in ARPE-19 cells—Implications for age-related macular degeneration (AMD)
- (2012) Anu Kauppinen et al. IMMUNOLOGY LETTERS
- The epidemiology of ocular and nasal allergy in the United States, 1988-1994
- (2010) Kavita Singh et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Carotenoid derived aldehydes-induced oxidative stress causes apoptotic cell death in human retinal pigment epithelial cells
- (2007) Nilesh M. Kalariya et al. EXPERIMENTAL EYE RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now